HLB Inno Acquires 13 Billion KRW Stake in Verismo Therapeutics
HLB Innovation announced on the 5th that it has acquired shares worth 13 billion KRW (3,184,714 shares) of Verismo Therapeutics, a biopharmaceutical company.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051914165468840_1779167814.png)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Not Jealous of Winning the Lottery"... Entire Village Stunned as 200 Million Won Jackpot of Wild Ginseng Cluster Discovered at Jirisan
- Controversy Over Mysterious Numbers at Starbucks: From Sewol Ferry and Park Geun-hye to May 18
- Cost Instability Grips 'AI Rally'... Iran War Identified as the Cause
- "How Did an Employee Who Loved Samsung End Up Like This?"... Past Video of Samsung Electronics Union Chairman Resurfaces
After the acquisition, the stake amounts to 11.75%. The company explained, "We participated in a third-party allotment capital increase and acquired the shares with cash, aiming to maximize corporate value."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
